Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
J Gynecol Oncol. 2019 Sep;30(5):e104. doi: 10.3802/jgo.2019.30.e104.
On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery support the following recommendations: According to the recently published phase III Laparoscopic Approach to Cervical Cancer (LACC) trial-a prospective randomized clinical trial-disease-free survival and overall survival rates of MIS RH are significantly lower than those of open RH. Gynecologic oncologists should be aware of the emerging data on MIS RH for early-stage cervical cancer. The results of the LACC trial, together with institutional data, should be discussed with patients before choosing MIS RH. MIS RH should be performed for optimal candidates according to the current practice guidelines by gynecologic oncologists who are skilled at performing MIS.
基于微创外科（MIS）治疗宫颈癌根治术（RH）的新数据和当前认识，韩国妇科肿瘤学会、韩国妇产科医师学会和韩国妇科内镜与微创外科学会支持以下建议：根据最近发表的 III 期腹腔镜宫颈癌治疗（LACC）试验——一项前瞻性随机临床试验，MIS RH 的无病生存率和总生存率明显低于开腹 RH。妇科肿瘤医生应该了解关于早期宫颈癌 MIS RH 的新数据。LACC 试验的结果以及机构数据应在选择 MIS RH 之前与患者进行讨论。根据妇科肿瘤医生熟练掌握的 MIS 实践指南，应仅在合适的候选者中施行 MIS RH。
